0001209191-21-007292.txt : 20210203
0001209191-21-007292.hdr.sgml : 20210203
20210203164751
ACCESSION NUMBER: 0001209191-21-007292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nolan Mangini Siobhan
CENTRAL INDEX KEY: 0001679464
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38853
FILM NUMBER: 21586816
MAIL ADDRESS:
STREET 1: C/O NMG BIOPHARMACEUTICALS, INC.
STREET 2: 333 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001426332
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-243-5555
MAIL ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-03
0
0001426332
NGM BIOPHARMACEUTICALS INC
NGM
0001679464
Nolan Mangini Siobhan
C/O NGM BIOPHARMACEUTICALS, INC.
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
18.88
2020-08-03
4
A
0
300000
0.00
A
2030-08-02
Common Stock
300000
300000
D
The shares subject to the stock option vest over a four-year period, with 1/4th vesting on July 13, 2021 and the remainder vesting in 36 equal monthly installments thereafter.
/s/ Valerie Pierce, Attorney-in-fact
2021-02-03